Olema Pharmaceuticals's market cap is currently $344.40M. The company's EPS TTM is $-2.189; its P/E ratio is ―; Olema Pharmaceuticals is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -377.00K	$ -1.66M	$ -1.66M	$ -11.00K	$ -9.03K
Operating Income	$ -104.96M	$ -106.99M	$ -71.49M	$ -21.53M	$ -4.32M
EBITDA	$ -104.58M	$ -103.13M	$ -69.43M	$ -21.52M	$ -4.31M
Net Income	$ -96.66M	$ -102.59M	$ -70.89M	$ -22.76M	$ -4.32M
Balance Sheet
Cash & Short-Term Investments	$ 261.81M	$ 204.42M	$ 287.25M	$ 338.55M	$ 68.00K
Total Assets	$ 276.94M	$ 215.65M	$ 295.94M	$ 342.72M	$ 132.00K
Total Debt	$ 2.42M	$ 2.56M	$ 3.29M	$ 0.00	$ 0.00
Net Debt	$ -66.12M	$ -21.14M	$ -283.96M	$ -338.55M	$ -68.00K
Total Liabilities	$ 23.05M	$ 18.10M	$ 11.38M	$ 4.58M	$ 10.73M
Stockholders' Equity	$ 253.90M	$ 197.55M	$ 284.57M	$ 338.14M	$ -10.59M
Cash Flow
Free Cash Flow	$ -83.73M	$ -82.43M	$ -52.27M	$ -19.92M	$ -3.08M
Operating Cash Flow	$ -83.73M	$ -82.06M	$ -50.69M	$ -19.87M	$ -3.08M
Investing Cash Flow	$ -4.85M	$ 91.48M	$ -275.44M	$ -56.00K	$ 0.00
Financing Cash Flow	$ 133.41M	$ 476.00K	$ 1.39M	$ 358.40M	$ 0.00

Currency in USD

Olema Pharmaceuticals Earnings and Revenue History

Income Statement >

Olema Pharmaceuticals Debt to Assets

Balance Sheet >

Olema Pharmaceuticals Cash Flow

Cash Flow >

Olema Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing